Publications in collaboration with researchers from Hospital Universitario Rey Juan Carlos (33)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

2023

  1. Analysis of infectious diseases care in Spanish hospitals from 2016–2020, including the first year of the SARS-CoV-2 pandemic

    Revista Clinica Espanola, Vol. 223, Núm. 5, pp. 310-315

  2. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  3. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

  4. Long-term outcomes in critically ill patients who survived COVID-19: The NUTRICOVID observational cohort study

    Clinical Nutrition, Vol. 42, Núm. 10, pp. 2029-2035

  5. Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)

    Oncology and Therapy, Vol. 11, Núm. 1, pp. 83-96

  6. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life

    Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402

2022

  1. Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study

    Clinical Nutrition, Vol. 41, Núm. 12, pp. 2934-2939

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  3. Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient

    Infectio, Vol. 26, Núm. 2, pp. 128-136

2021

  1. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  2. HIV-DNA content in pTfh cells is associated with residual viremia in elite controllers

    AIDS, Vol. 35, Núm. 3, pp. 393-398

  3. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  4. Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

    Journal of the Neurological Sciences, Vol. 423

  5. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  6. Risk factors and mortality of COVID-19 in patients with lymphoma: A multicenter study

    HemaSphere, Vol. 5, Núm. 3, pp. 1-8

  7. Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life

    Parkinson's Disease, Vol. 2021

  8. The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: The SeroSOS study

    Age and Ageing, Vol. 50, Núm. 4, pp. 1038-1047

2020

  1. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

  2. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

    Journal of the Neurological Sciences, Vol. 418